健康研究
健康研究
건강연구
HEALTH RESEARCH
2015年
1期
30-32
,共3页
胸腔穿刺%气腹针%并发症
胸腔穿刺%氣腹針%併髮癥
흉강천자%기복침%병발증
veress needle%pleural effusion%thoracentesis
目的:探讨气腹针用于单纯胸腔穿刺抽液的临床疗效。方法胸腔积液需行单纯胸腔穿刺抽液的131例患者随机分成3组,分别以普通针头( A组)、静脉套管针( B组)和气腹针( C组)行穿刺抽液。结果131例患者共穿刺378次,平均每例患者穿刺2.88次。 C组的穿刺成功率显著高于A组和B组(均P<0.05);穿刺中止主要原因:A 组为医源性气胸(50.0%,6/12)和胸膜反应(25.0%,3/12),B 组为堵管(55.6%,5/9)和医源性气胸(33.3%,3/9),C组为胸膜反应(66.7%,2/3);末次穿刺抽液后胸腔内残留积液深度:C组显著低于A组和B组(均P<0.05)。结论应用气腹针行单纯性胸腔穿刺抽液,操作简单、方便,成功率高,并发症少。
目的:探討氣腹針用于單純胸腔穿刺抽液的臨床療效。方法胸腔積液需行單純胸腔穿刺抽液的131例患者隨機分成3組,分彆以普通針頭( A組)、靜脈套管針( B組)和氣腹針( C組)行穿刺抽液。結果131例患者共穿刺378次,平均每例患者穿刺2.88次。 C組的穿刺成功率顯著高于A組和B組(均P<0.05);穿刺中止主要原因:A 組為醫源性氣胸(50.0%,6/12)和胸膜反應(25.0%,3/12),B 組為堵管(55.6%,5/9)和醫源性氣胸(33.3%,3/9),C組為胸膜反應(66.7%,2/3);末次穿刺抽液後胸腔內殘留積液深度:C組顯著低于A組和B組(均P<0.05)。結論應用氣腹針行單純性胸腔穿刺抽液,操作簡單、方便,成功率高,併髮癥少。
목적:탐토기복침용우단순흉강천자추액적림상료효。방법흉강적액수행단순흉강천자추액적131례환자수궤분성3조,분별이보통침두( A조)、정맥투관침( B조)화기복침( C조)행천자추액。결과131례환자공천자378차,평균매례환자천자2.88차。 C조적천자성공솔현저고우A조화B조(균P<0.05);천자중지주요원인:A 조위의원성기흉(50.0%,6/12)화흉막반응(25.0%,3/12),B 조위도관(55.6%,5/9)화의원성기흉(33.3%,3/9),C조위흉막반응(66.7%,2/3);말차천자추액후흉강내잔류적액심도:C조현저저우A조화B조(균P<0.05)。결론응용기복침행단순성흉강천자추액,조작간단、방편,성공솔고,병발증소。
Objective To explore the clinical values of veress needle for thoracentesis .Method 131 Patients with pleural effusion were divided into three groups , namely, groug A, B, and C.The groups were then given different methods of thoracentesis .Group A were punctured with regular needle for clinical use;Group B were with trocar needle and Group C were with veress needle .Findings The successful ratio of puncture of Group C was significantly higher than those of Group A and Group B(all P<0.05).The residual effusion after the last time of puncture in Group C was significantly less than those of Group A and Group B(all P<0.05).Conclusion Thoracentesis by veress needle is convenient , operational, safe and practical .It is worthy of being recommend in clinical practice .